Imunon Inc. (IMNN)
NASDAQ: IMNNHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
IMNN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $6.00M
- EPS (TTM)
- -$3.84
- Dividend yield
- None
- 52-week range
- 1.04 – 5.39
- Day range
- 1.04 – 1.18
- Volume / Avg
- 131.13K / 153.67K
- Beta
- —
- Shares outstanding
- 5.61M
52-week range
IMNN stock today
Imunon (IMNN) closed at $1.07 on Oct 8, down 4.46% (-$0.05), versus the S&P 500's 0.47% decline. At this level, IMNN sits near the bottom of its 52-week range of $1.04 to $5.39: 80.1% below the high and 2.9% above the low. Imunon has posted a net loss over the last twelve months (EPS of -$3.84), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Imunon
Company profileImunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma. It is also developing IMNN-101, a COVID-19 booster vaccine that has completed a Phase 1 clinical trial.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Stacy R. Lindborg Ph.D.
- Headquarters
- Lawrenceville, NJ
- Employees
- 20
- Website
- imunon.com
Analyst forecast
ForecastConsensus (4 analysts)
strong_buy
Avg. price target
$17.00+1488.79%
- Strong buy 1
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
IMNN news
All IMNN newsImunon peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CANFCan-Fite Biopharma Ltd ADR | 2.00 | -4.76% | $6.06M | vs IMNN |
| KALAKALA BIO Inc. | 0.2966 | -17.61% | $5.74M | vs IMNN |
| EVGNEvogene Ltd | 0.3985 | -2.95% | $6.30M | vs IMNN |
| PULMPulmatrix Inc. | 1.53 | +2.49% | $5.58M | vs IMNN |
| ADXNAddex Therapeutics Ltd ADR | 3.18 | +6.81% | $5.57M | vs IMNN |
| ALZNAlzamend Neuro Inc. | 1.34 | -2.19% | $6.47M | vs IMNN |
| ENLVEnlivex Ltd. | 0.277 | -10.85% | $5.51M | vs IMNN |
| CDIOCardio Diagnostics Holdings Inc. | 1.86 | -5.58% | $5.50M | vs IMNN |
Indexes, lists and sector
Appears in lists
Imunon stock FAQ
What is Imunon's stock price today?
IMNN last traded at $1.07 as of Oct 8, 4:00 PM EDT, down 4.46% on the day. Prices are delayed at least 15 minutes.
Who is Imunon's CEO?
Dr. Stacy R. Lindborg Ph.D. is the chief executive officer of Imunon Inc., which has about 20 employees.
What is the IMNN 52-week high?
The 52-week high for IMNN is $5.39 and the 52-week low is $1.04. The stock is currently 80.1% below its high.